An observational study in Eye Abnormalities and Normal Eyes, sponsored by Topcon Corporation. Completed at 1 site in United States. Open to participants aged 22 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-02-04.
Sponsored by Topcon Corporation · Observational
To evaluate the performance of pachymetry function
28 studies on the registry are indexed under Eye Abnormalities; 3 are open to participants now.
This study's enrollment of 108 is close to the median of 100 across 14 observational studies indexed under Eye Abnormalities.
Browse Eye Abnormalities studies →Topcon Corporation is the lead sponsor of 11 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Subjects seeing an eye doctor that have normal cornea, cornea abnormality, or glaucoma
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Subjects with healthy cornea
Device: Pachymeter
Subjects with abnormal cornea
Device: Pachymeter
Subjects with glaucoma
Device: Pachymeter
Measure the thickness of the cornea
Also known as: TRK-3 auto kerato-refracto tonometer
Cornea thickness
thickness of the cornea
Time frame: 1 day
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.